$3.30
-0.07-2.08%
At Close: -
$3.26
-0.04-1.21%
After Hours: Jul 22, 4:04 PM EDT
15 minutes delayed
Comments
Loading...
Athira Pharma
ATHANASDAQ
Athira Pharma (NASDAQ:ATHA) Stock, Insider Trading Activity
Athira Pharma: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Athira Pharma Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On June 25, 2024, Kelly A Romano, the company's - purchased 42.4K shares for $2.36 each.
Ownership Statistics for Athira Pharma Inc
Institutional Shares Held
5.511M
Institutional Percentage Held
14.4%
| Jun 25, 2024 | Kelly A Romano | — | 42.40K | $2.36 | $100.05K | BUY | 110.66% | 80.72K | Jun 21 - Jun 24 | View |
| Jan 08, 2024 | Andrew Gengos | SEE BELOW | 3.79K | $2.91 | -$3.52K | GRANT | 4.74% | 83.80K | Jan 04 - Jan 05 | View |
| Jan 08, 2024 | Mark Litton | CHIEF EXECUTIVE OFFICER | 15.18K | $2.91 | -$14.03K | GRANT | 11.18% | 150.96K | Jan 04 - Jan 05 | View |
| Jan 08, 2024 | Mark Worthington | GENERAL COUNSEL | 15.36K | $2.66 | $11.70K | GRANT | 80.41% | 34.45K | May 18 - Jan 05 | View |
| Jan 08, 2024 | Kevin Church | CHIEF SCIENTIFIC OFFICER | 11.79K | $2.23 | -$517.25 | GRANT | 17.23% | 80.26K | Jan 04 - Nov 20 | View |
| Jan 08, 2024 | Rachel Lenington | CHIEF OPERATING OFFICER | 7.59K | $2.91 | -$7.02K | GRANT | 130.67% | 13.39K | Jan 04 - Jan 05 | View |
| Dec 29, 2023 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | DIRECTOR | 605.69K | $2.42 | $1.46M | BUY | 12.63% | 5.40M | Dec 27 - Dec 29 | View |
| Jun 09, 2023 | Andrew Gengos | SEE BELOW | 15.00K | $3.43 | $51.45K | BUY | 23.07% | 80.01K | Jun 07 | View |
| Jun 06, 2023 | Andrew Gengos | SEE BELOW | 65.01K | $2.95 | $191.57K | BUY | ∞ | 65.01K | Jun 02 - Jun 05 | View |
| Mar 31, 2023 | Grant Pickering | DIRECTOR | 25.00K | $2.41 | $60.35K | BUY | 3192.85% | 25.78K | Mar 29 - Mar 30 | View |
| Mar 30, 2023 | James A Johnson | DIRECTOR | 5.00K | $2.40 | $12.00K | BUY | ∞ | 5.00K | Mar 29 | View |
| Dec 30, 2022 | Glenna Mileson | CHIEF FINANCIAL OFFICER | 50.76K | $2.84 | $144.34K | BUY | 46.50% | 159.93K | Nov 18 - Dec 28 | View |
| Dec 06, 2022 | Kelly A Romano | DIRECTOR | 30.00K | $3.29 | $98.70K | BUY | 360.79% | 38.31K | Dec 02 | View |
| Nov 17, 2022 | Hans Moebius | CHIEF MEDICAL OFFICER | 5.00K | $3.29 | $16.44K | BUY | 8.22% | 65.84K | Nov 15 | View |
| Jul 01, 2022 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | DIRECTOR | 1.37M | $2.99 | $4.10M | BUY | 40.03% | 4.80M | Jun 29 - Jun 30 | View |
| Jun 30, 2022 | Hans Moebius | CHIEF MEDICAL OFFICER | 10.00K | $2.88 | $28.80K | BUY | 23.28% | 52.95K | Jun 28 | View |
| Jun 24, 2022 | Mark Worthington | GENERAL COUNSEL | 10.78K | $4.88 | $16.94K | GRANT | 129.67% | 19.10K | May 18 - Jun 23 | View |
| Jun 24, 2022 | Glenna Mileson | CHIEF FINANCIAL OFFICER | 9.11K | $4.88 | $5.12K | GRANT | 9.10% | 109.17K | May 18 - Jun 23 | View |
| Jun 24, 2022 | Mark Litton | CHIEF EXECUTIVE OFFICER | 12.80K | $4.88 | -$16.07K | GRANT | 10.46% | 135.12K | May 18 - Jun 23 | View |
| Jun 24, 2022 | Rachel Lenington | CHIEF OPERATING OFFICER | 5.81K | $2.69 | -$11.28K | GRANT | ∞ | 5.81K | Jun 22 - Jun 23 | View |
| Jun 24, 2022 | Kevin Church | EXECUTIVE VP, RESEARCH | 7.39K | $2.69 | -$7.03K | GRANT | 14.68% | 57.70K | Jun 22 - Jun 23 | View |
| Apr 01, 2022 | Kelly A Romano | DIRECTOR | 8.00K | $13.11 | $104.88K | BUY | 2539.68% | 8.31K | Mar 31 | View |
| Jan 27, 2021 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | DIRECTOR | 311.11K | $22.50 | $7.00M | BUY | 9.99% | 3.43M | Jan 25 | View |
| Sep 22, 2020 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTD | — | 2.70M | $17.00 | $18.00M | DERIVATIVE CONVERSION | 657.50% | 3.11M | Sep 22 | View |
| Sep 22, 2020 | Joseph Edelman | — | 2.70M | $17.00 | $18.00M | DERIVATIVE CONVERSION | 657.50% | 3.11M | Sep 22 | View |
| Sep 22, 2020 | RTW INVESTMENTS LPRODERICK WONG | — | 2.29M | $17.00 | $12.75M | DERIVATIVE CONVERSION | 595.42% | 2.67M | Sep 18 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.